This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Spector, B. Articles by Shaughnessy, D. Social Bookmarking                         What's this?

Developing Innovation Transfer Capacity in a Cross-National Firm

Northeastern University

Henry W. Lane

Northeastern University

Dennis Shaughnessy

Northeastern University

The study presented in this article analyzes an attempt to transfer a discontinuous product innovation across national boundaries within a biopharmaceutical company. The commercialization process, which had been effective within the company's home market, was less effective in Europe and Japan. The study concludes that when the company engaged in a transformational change intervention, it was able to improve the effectiveness of its international transfer process. The changes required were emergent rather than planned; they were driven by a renewed strategy and did not use the tools of OD nor embed itself in the humanistic values typically associated with OD. The study provides insight into the requirements of product transfer and commercialization to international subsidiaries, which needs to be approached as an international organizational change process, which the authors define as strategically aligned alterations in patterns of employee behavior across international borders.

Key Words: international organization change • innovation • international studies • biopharmaceutical industry

The Journal of Applied Behavioral Science, Vol. 45, No. 2, 261-279 (2009)
DOI: 10.1177/0021886309334034


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?